Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Paroxysmal positive symptoms caused by hardware malfunctioning in deep brain stimulation.

de Andrade DC, Gurruchaga JM, Jarraya B, Goujon C, Beaugendre Y, Lepetit H, Tani N, Mandat T, Kirov K, Fenelon G, Brugières P, Palfi S.

Brain Stimul. 2010 Jan;3(1):61-2. doi: 10.1016/j.brs.2009.07.002. Epub 2009 Aug 12. No abstract available.

PMID:
20633434
2.

Deep brain stimulation for Parkinson's disease.

[No authors listed]

Med Lett Drugs Ther. 2009 Apr 6;51(1309):26-7. No abstract available.

PMID:
19343007
3.

Subthalamic deep brain stimulation masking possible malignant syndrome in Parkinson disease.

Linazasoro G, Van Blercom N, Castro A, Dapena MD.

Neurology. 2004 Aug 10;63(3):589-90. No abstract available.

PMID:
15304607
4.

[Anesthetic management of a patient with deep brain stimulators].

Okajima H, Ushio M, Higuchi Y, Tanaka Y, Iijima K, Horikawa Y, Ijichi K, Tanaka O.

Masui. 2007 Oct;56(10):1211-3. Japanese.

PMID:
17966631
5.

Parkinson's goal: ease symptoms, slow progression.

[No authors listed]

Johns Hopkins Med Lett Health After 50. 2006 Jun;18(4):4-5. No abstract available.

PMID:
16795901
6.

Parkinson's disease: recent development in therapies for advanced disease with a focus on deep brain stimulation (DBS) and duodenal levodopa infusion.

Sydow O.

FEBS J. 2008 Apr;275(7):1370-6. doi: 10.1111/j.1742-4658.2008.06295.x. Epub 2008 Feb 12. Review.

7.

Is there a role for physiotherapy during deep brain stimulation surgery in patients with Parkinson's disease?

Chevrier E, Fraix V, Krack P, Chabardes S, Benabid AL, Pollak P.

Eur J Neurol. 2006 May;13(5):496-8.

PMID:
16722975
8.

Treatment frontiers.

Smith K.

Nature. 2010 Aug 26;466(7310):S15-8. doi: 10.1038/466S15a. No abstract available. Erratum in: Nature. 2010 Sep 30;467(7315):622.

PMID:
20739932
9.

Eyelid apraxia associated with subthalamic nucleus deep brain stimulation.

Shields DC, Lam S, Gorgulho A, Emerson J, Krahl SE, Malkasian D, DeSalles AA.

Neurology. 2006 May 9;66(9):1451-2. No abstract available.

PMID:
16682687
10.

[Continuous dopaminergic stimulation in Parkinson disease: possibilities in 2013].

Aschermann Z, Kovács N, Komoly S.

Ideggyogy Sz. 2013 May 30;66(5-6):209-10. Hungarian. No abstract available.

PMID:
23909024
11.

The effects of deep brain stimulation and levodopa on postural sway in subjects with Parkinson's disease.

Burn DJ.

J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):240. No abstract available.

12.

Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.

Piboolnurak P, Lang AE, Lozano AM, Miyasaki JM, Saint-Cyr JA, Poon YY, Hutchison WD, Dostrovsky JO, Moro E.

Mov Disord. 2007 May 15;22(7):990-7.

PMID:
17443692
13.

Deep brain stimulation for movement disorders: what counts in the end is the end result.

Warnke P.

J Neurol Neurosurg Psychiatry. 2014 May;85(5):474. doi: 10.1136/jnnp-2013-305832. Epub 2013 Oct 9. No abstract available.

PMID:
24108058
14.

Transient disabling dyskinesias: a predictor of good outcome in subthalamic nucleus deep brain stimulation in Parkinson's disease.

Gago MF, Rosas MJ, Linhares P, Ayres-Basto M, Sousa G, Vaz R.

Eur Neurol. 2009;61(2):94-9. doi: 10.1159/000177941. Epub 2008 Nov 28.

PMID:
19039227
15.

The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease.

Giannicola G, Marceglia S, Rossi L, Mrakic-Sposta S, Rampini P, Tamma F, Cogiamanian F, Barbieri S, Priori A.

Exp Neurol. 2010 Nov;226(1):120-7. doi: 10.1016/j.expneurol.2010.08.011. Epub 2010 Aug 14.

PMID:
20713047
16.

New and emerging treatments for Parkinson disease.

Fung VS.

Med J Aust. 2015 Apr 6;202(6):283-4. No abstract available.

PMID:
25832138
17.

Apraxia of eyelid opening after subthalamic deep brain stimulation may be caused by reduction of levodopa.

Umemura A, Toyoda T, Yamamoto K, Oka Y, Ishii F, Yamada K.

Parkinsonism Relat Disord. 2008 Dec;14(8):655-7. doi: 10.1016/j.parkreldis.2007.12.008. Epub 2008 Mar 3.

PMID:
18316231
18.

Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease.

Merola A, Zibetti M, Angrisano S, Rizzi L, Lanotte M, Lopiano L.

Mov Disord. 2011 Mar;26(4):664-70. doi: 10.1002/mds.23524. Epub 2011 Apr 5.

PMID:
21469197
19.

Levodopa and subthalamic deep brain stimulation responses are not congruent.

Zaidel A, Bergman H, Ritov Y, Israel Z.

Mov Disord. 2010 Oct 30;25(14):2379-86. doi: 10.1002/mds.23294.

PMID:
20824733
20.

[Experiences with stereotaxis in Parkinson patients treated with levodopa].

Bosch DA, Pasmans J, Lakke JP.

Ned Tijdschr Geneeskd. 1983 Feb 26;127(9):383-8. Dutch. No abstract available.

PMID:
6339959
Items per page

Supplemental Content

Write to the Help Desk